KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Non-Current Assets (2016 - 2026)

Idexx Laboratories has reported Non-Current Assets over the past 17 years, most recently at $1.9 billion for Q4 2025.

  • For Q4 2025, Non-Current Assets rose 2.29% year-over-year to $1.9 billion; the TTM value through Dec 2025 reached $1.9 billion, up 2.29%, while the annual FY2025 figure was $1.9 billion, 2.29% up from the prior year.
  • Non-Current Assets for Q4 2025 was $1.9 billion at Idexx Laboratories, up from $1.9 billion in the prior quarter.
  • Over five years, Non-Current Assets peaked at $2.0 billion in Q2 2025 and troughed at $1.2 billion in Q1 2021.
  • A 5-year average of $1.7 billion and a median of $1.7 billion in 2023 define the central range for Non-Current Assets.
  • Biggest five-year swings in Non-Current Assets: grew 22.82% in 2021 and later dropped 0.38% in 2025.
  • Year by year, Non-Current Assets stood at $1.5 billion in 2021, then increased by 11.05% to $1.6 billion in 2022, then rose by 7.26% to $1.8 billion in 2023, then rose by 7.3% to $1.9 billion in 2024, then rose by 2.29% to $1.9 billion in 2025.
  • Business Quant data shows Non-Current Assets for IDXX at $1.9 billion in Q4 2025, $1.9 billion in Q3 2025, and $2.0 billion in Q2 2025.